find the latest legal job
Corporate Counsel and Company Secretary
Category: Generalists - In House | Location: Newcastle, Maitland & Hunter NSW
· Highly-respected, innovative and entrepreneurial Not-for-Profit · Competency based Board
View details
Chief Counsel and Company Secretary
Category: Generalists - In House | Location: Newcastle, Maitland & Hunter NSW
· Dynamic, high growth organisation · ASX listed market leader
View details
In-house Projects Lawyer | Renewables / Solar | 2-5 Years PQE
Category: Generalists - In House | Location: All Australia
· Help design the future · NASDAQ Listed
View details
Insurance Lawyer (3-5 PAE)
Category: Insurance and Superannuation Law | Location: Brisbane CBD & Inner Suburbs Brisbane QLD
· Dynamic organisation ·
View details
Legal Counsel
Category: Corporate and Commercial Law | Location: North Sydney NSW 2060
· 18 month fixed term contract · 3-5 years PQE with TMT exposure
View details
Middletons acts on billion dollar biotech deal

Middletons acts on billion dollar biotech deal

Middletons has acted for Mesoblast on an equity and licensing deal with initial upfront payments of approximately $US350 million, and milestone payments of up to $US1.7 billion, with Mesoblast…

Middletons has acted for Mesoblast on an equity and licensing deal with initial upfront payments of approximately $US350 million, and milestone payments of up to $US1.7 billion, with Mesoblast retaining the manufacturing rights for its products to be sold to Cephalon.

It is believed to be one of the largest phase two stage biotech deals ever completed, with many commentators now suggesting the entire potential deal value to be well over $US2 billion, plus revenue sharing.

Middletons' lead biotechnology partner on the deal, Peter Howard, said: "Mesoblast has granted Cephalon exclusive rights to commercialise specified cardiac, central nervous disorder and oncology products based on Mesoblast's proprietary adult stem cell technology platform."

The deal does not cover the area of orthopaedics, diabetes, eye diseases and immune based inflammatory diseases.

"This is a fantastic outcome for our client and a transformational deal for both parties. Under the deal, Cephalon will now partner with Mesoblast on clinical development and delivery and Mesoblast is free to use the technology in its other applications outside of this mutually beneficial relationship," Howard said.

According to Middletons, deal was truly unique in that no bankers or financiers were involved on the transaction for Mesoblast.

Middletons acted in concert with US law firm Wilson Sonsini Goodrich & Rosati.

Like this story? Read more:

QLS condemns actions of disgraced lawyer as ‘stain on the profession’

NSW proposes big justice reforms to target risk of reoffending

The legal budget breakdown 2017

Middletons acts on billion dollar biotech deal
lawyersweekly logo
Promoted content
Recommended by Spike Native Network
more from lawyers weekly
LCA president Fiona McLeod SC
Aug 17 2017
Where social fault lines meet the justice gap in Aus
After just returning from a tour of the Northern Territory, LCA president Fiona McLeod SC speaks wit...
Marriage equality flag
Aug 17 2017
ALHR backs High Court challenge to marriage equality postal vote
Australian Lawyers for Human Rights (ALHR) has voiced its support for a constitutional challenge to ...
Give advice
Aug 17 2017
A-G issues advice on judiciary’s public presence
Commonwealth Attorney-General George Brandis QC has offered his advice on the public presence of jud...
APPOINTMENTS
Allens managing partner Richard Spurio, image courtesy Allens' website
Jun 21 2017
Promo season at Allens
A group of lawyers at Allens have received promotions across its PNG and Australian offices. ...
May 11 2017
Partner exits for in-house role
A Victorian lawyer has left the partnership of a national firm to start a new gig with state governm...
Esteban Gomez
May 11 2017
National firm recruits ‘major asset’
A national law firm has announced it has appointed a new corporate partner who brings over 15 years'...
opinion
Nicole Rich
May 16 2017
Access to justice for young transgender Australians
Reform is looming for the process that young transgender Australians and their families must current...
Geoff Roberson
May 11 2017
The lighter side of the law: when law and comedy collide
On the face of it, there doesn’t seem to be much that is amusing about the law, writes Geoff Rober...
Help
May 10 2017
Advocate’s immunity – without fear or without favour but not both
On 29 March 2017, the High Court handed down its decision in David Kendirjian v Eugene Lepore & ...